Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Endocrinology drugs market size to grow by USD 36551.24 Million: Increase in the incidence of endocrine disorders remains key growth driver - Technavio


NEW YORK, Dec. 7, 2022 /PRNewswire/ -- The global endocrinology drugs market size is set to grow by USD 36551.24 million from 2022 to 2027, according to Technavio. The growth momentum of the market will accelerate at a CAGR of 7.82% during the forecast period. This report provides analysis and insights to enable effective decision-making. Download A Sample Report

Endocrinology drugs market - Key Driver and Major Challenge

The increase in the incidence of endocrine disorders is driving the endocrinology drug market growth. The prevalence of endocrine disorders such as diabetes is increasing globally, especially in low and middle-income countries. The incidence of such disorders is high in the aging population. With advances in healthcare technology, the average life expectancy of people has increased considerably across the world. This has resulted in an increase in the aging population worldwide. Thus, the rising incidence of endocrine disorders and the expanding aging population are expected to drive the growth of the global endocrinology drugs market during the forecast period.

The expiring patents of major endocrinology drugs are impeding the endocrinology drug market growth. Endocrinology drugs were available in the market since 1995, and many of the approved drugs available back then are on the verge of expiring. For instance, Lantus, one of the world's most widely prescribed insulin, lost its patent in February 2015. Similarly, NovoLog/NovoRapid's patent expired in 2014. These forthcoming patent expirations paved the way for generic drugs, resulting in the loss of market share by branded drug manufacturers. This is expected to reduce the growth potential in the market over the forecast period.

Technavio has identified key trends, drivers, and challenges, along with competitive analysis to help clients improve their strategies to stay ahead of their competitors. Buy the report to obtain detailed insights about the market.

Major five endocrinology drugs companies

Other key vendors

Get lifetime access to our Technavio Insights! Subscribe to our Basic Plan billed annually at USD 5000

Endocrinology Drugs Market Therapy Area Outlook (Revenue, USD mn, 2022-2027)
Endocrinology Drugs Market Distribution Channel Outlook (Revenue, USD mn, 2022-2027)
Endocrinology Drugs Market Geography Outlook (Revenue, USD mn, 2022-2027)

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report

What are the key data covered in this endocrinology drugs market report?

Related Reports

Endocrinology Drugs Market Scope

Report Coverage

Details

Page number

172

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 7.82%

Market growth 2023-2027

USD 36551.24 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

6.52

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 45%

Key countries

US, Canada, UK, Germany, and China

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Acerus Pharmaceuticals Corp., Ascendis Pharma AS, Bayer AG, Beta Cell NV, Biocon Ltd., Eli Lilly and Co., Endo International Plc, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hanmi Pharm Co. Ltd., Ipsen Pharma, Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Oramed Pharmaceuticals Inc., Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and VeroScience LLC

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of contents:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Therapy Area

7 Market Segmentation by Distribution Channel

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 22:54
Summit Industrial Income REIT ("Summit" or the "REIT") is pleased to announce the receipt of approval under the Investment Canada Act in respect of the previously announced plan of arrangement transaction that was approved by the Ontario Superior...

at 21:50
President Biden has delivered on his promise to create jobs, with our country witnessing record-breaking job creation over the last year. But gender and racial inequities in job growth remain and women and some ethnic groups continue to lag behind....

at 21:15
The Burn Care Market by Therapy, Type, and Geography - Forecast and Analysis - 2023-2027 report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 5.27% and register an incremental growth of USD 843.34 million...

at 21:05
Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the pricing of its previously announced underwritten public offering of...

at 21:00
According to Technavio, the global 3D printer market size is estimated to grow by USD 25,095.58 million from 2022 to 2027. The market is estimated to grow at a CAGR of 23.49% during the forecast period. North America held the largest share of the...

at 20:45
According to Technavio, the global water bottles with filters market size is estimated to grow by USD 266.01 million from 2022 to 2027. The market is estimated to grow at a CAGR of 14.79% during the forecast period. North America held the largest...



News published on 7 december 2022 at 18:30 and distributed by: